Frank Rimerman Advisors LLC Sells 2,350 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Frank Rimerman Advisors LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 16,588 shares of the pharmacy operator’s stock after selling 2,350 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Walgreens Boots Alliance were worth $155,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. State Street Corp increased its holdings in Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after buying an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 19.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after buying an additional 2,185,950 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Walgreens Boots Alliance by 12.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after purchasing an additional 817,762 shares during the last quarter. Thompson Siegel & Walmsley LLC grew its holdings in Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after purchasing an additional 934,754 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Walgreens Boots Alliance by 9.6% in the fourth quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock worth $50,684,000 after purchasing an additional 478,061 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

WBA has been the topic of several analyst reports. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price target for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Finally, StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research note on Tuesday. They set a “hold” rating for the company. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Stock Up 0.3 %

WBA stock opened at $11.26 on Tuesday. The stock has a market capitalization of $9.73 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.62. The firm has a 50-day simple moving average of $10.86 and a 200-day simple moving average of $9.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the prior year, the company earned $0.66 EPS. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.